WHO issues new guidelines to reduce surgical infections and spread of superbugs

The World Health Organization (WHO) has released new global guidelines covering surgical site infections (SSIs) with a view to reduce costs associated with SSI related patient complications.

The guidelines were made in response to the impact of SSIs on global healthcare systems based on financial terms as well as patient outcome.

WHO developed the guidelines based on findings of a systematic review and meta-analysis of 21 studies including both randomised controlled trials and observational studies using ACELITY negative pressure therapy products.

Results of the study suggested that usage of pNPWT reduced the risk of SSIs compared to conventional dry gauze dressings. 

The new guidelines suggest the usage of prophylactic negative pressure wound therapy (pNPWT, or closed incision negative pressure therapy [ciNPT]) on primarily closed surgical incisions in high-risk wounds to prevent SSIs.

Acelity chief medical officer Ron Silverman said: “The new WHO guidelines build upon a significant body of evidence that illustrates the impact negative pressure therapy can have in reducing the incidence of surgical site infections.

“We developed PREVENA Therapy as the first disposable powered negative pressure system designed specifically for the management of closed surgical incisions six years ago, building off our demonstrated expertise in this space."